 FSD Pharma CSE:HUGE, NASDAQ:HUGE Inc said its board of directors has authorized the repurchase by the company of up to 2 million of its subordinate Class B voting shares, being approximately 5 of its issued and outstanding subordinate voting shares, from time to time over the next 12 months. The company said the share repurchase programme will allow it to use its excess cash reserves to strategically return value to shareholders. 